Search Results 361-370 of 17229 for GLP-1 therapy

  1. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

    Giving durvalumab and tremelimumab with radiation therapy may work better in treating patients with colorectal or non-small cell lung cancer. Participation ...

  2. A Study to Optimize Endocrine Therapy Through Motivational Interviewing and Text Interventions - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB. Albert ...

  3. Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors - Mayo Clinic

    Part 1: have tumor progression following standard therapy, have treatment-refractory disease, or for whom there is no effective standard of therapy; Part 2c ...

  4. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    Patients can be enrolled and begin study therapy with ofatumumab within 14 days from initiation of 1 mg/kg/day prednisone for therapy of chronic GVHD.

  5. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

    ... therapy or greater). Ovarian cancer (including fallopian tube cancer). Has progressed following at least 1 prior systemic therapy for advanced or metastatic ...

  6. Domperidone (oral route) - Side effects & dosage - Mayo Clinic

    ... treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Kratom ...

  7. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest ...

  8. Neurology - Clinical trials - Mayo Clinic

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  9. A Study to Evaluate Pembrolizumab with Standard Therapy to Treat Newly-diagnosed Glioblastoma - Mayo Clinic

    ... treatment works better than the current standard therapy. ... 1 trial. Phase 4 trials look at long-term safety ... Giving pembrolizumab and standard therapy ...

  10. Impact Of Aromatase Inhibitor Therapy On Glucose Homeostasis And Diabetes Risk - Mayo Clinic

    This study assesses the effect of hormone directed treatment for breast cancer or ductal carcinoma in situ (DCIS) on glucose metabolism. Participation ...